Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/0R55 stock hub

LON/0R55 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0R55is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.2M
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0R55
In the news

Latest news · LON/0R55

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 16.9P75 23.5
Trailing P/En/a
P25 15.9P50 22.9P75 35.8
ROEn/a
P25 -54.2P50 2.1P75 13.7
ROIC-101.6
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0R55 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
142
Groups with data
11
Currency
EUR
Showing 142 of 142 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Belgium
Country code
UK
Employees
7
Employees Change
5%
Employees Change Percent
250
Enterprise value
EUR 21.1M
Exchange
London Stock Exchange
Financial currency
EUR
First seen
2026-05-10
Industry
Biotechnology
Isin
BE0974280126
Last refreshed
2026-05-10
Market cap
EUR 1.2M
Price
EUR 0
Price currency
EUR
Rev Per Employee
-292,302.86x
Sector
Healthcare
Sic
2836
Symbol
lon/0R55
Website
https://www.biosenic.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

4
MetricValue
Earnings Yield
-276.09%
EV Earnings
-6.17x
P/B ratio
-0.06x
P/S ratio
-0.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

11
MetricValue
Gross Profit
EUR -2M
Gross Profit Growth Q
-99.96%
Net Income
EUR -3.4M
Net Income Growth Quarters
1%
Net Income Growth Years
2%
Pretax Margin
248.76%
Profit Per Employee
EUR -489,335
Profitable Years
1
ROA
-46.2
ROCE
181.8
ROIC
-101.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
10.01%
Cagr3y
-71.7%
EPS Growth Quarters
1
EPS Growth Years
2
Revenue Growth
-69.64x
Revenue Growth Q
-99.96x
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

15
MetricValue
Assets
EUR 3.9M
Cash
EUR 429,454
Current Assets
EUR 3.3M
Current Liabilities
EUR 6.3M
Debt
EUR 20.2M
Equity
EUR -20.2M
Interest Coverage
-5.28
Liabilities
EUR 24.1M
Long Term Assets
EUR 514,887
Long Term Liabilities
EUR 17.8M
Net Cash
EUR -19.7M
Net Cash By Market Cap
EUR -1,591
Tangible Book Value
EUR -20.2M
Tangible Book Value Per Share
EUR -0.03
WACC
2.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
0.53
Net Working Capital
EUR -1M
Quick ratio
0.5
Working Capital
EUR -3M
Working Capital Turnover
EUR 0.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-150.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

33
MetricValue
1Y total return
10%
200-day SMA
0
3Y total return
-97.74%
50-day SMA
0
50-day SMA vs 200-day SMA
50under200
All Time High
0.35
All Time High Change
-99.36%
All Time High Date
2022-10-27
All Time Low
0
All Time Low Change
120%
All Time Low Date
2025-04-24
ATR
0
Beta
-1.67
Ch YTD
-4.35
High
0
High52
0
High52 Date
2025-06-23
High52ch
-31.25%
Low
0
Low52
0
Low52 Date
2025-05-09
Low52ch
57.14%
Ma50ch
-4.35%
Price vs 200-day SMA
-8.33%
RSI
49.65
RSI Monthly
33.24
RSI Weekly
42.8
Sharpe ratio
0.82x
Sortino ratio
1.39
Total Return
-150.43%
Tr YTD
-4.35
Tr1m
-8.33%
Tr3m
-12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -4.4M
Operating margin
215.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
603,174,546%
Net Borrowing
890,117.6
Shares Institutions
0.34%
Shares Qo Q
144.57%
Shares Yo Y
150.43%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

39
MetricValue
Average Volume
112,678.2x
Bv Per Share
-0.03
Ch1m
-8.33
Ch1y
10
Ch3m
-12
Ch3y
-97.74
Ch6m
-4.35
Change
10%
Change From Open
10
Close
0
Days Gap
0
Depreciation Amortization
285,893
Dollar Volume
4.65
Earnings Date
2026-05-11
EBIT
EUR -4.4M
EBITDA
EUR -4.1M
EPS
EUR -0.01
F Score
3
Financing CF
1,539,519
Fiscal Year End
December
Investing CF
51,432
Is Primary Listing
0
Last Earnings Date
2025-10-27
Last Report Date
2025-06-30
Ma150
0
Ma150ch
-4.35%
Ma20
0
Ma20ch
0%
Net CF
27,430
Next Earnings Date
2026-05-11
Open
0
Position In Range
100
Ppne
2,595.1
Price Date
2026-05-08
Relative Volume
0.02x
Revenue
-2,046,120x
Tr6m
-4.35%
Volume
2,112
Z Score
-29.39
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does LON/0R55 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0R55 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+10.0%
S&P 500 1Y: n/a
3Y total return
-97.7%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0R55?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.3%
Share of float held by funds and institutions
Insider ownership
n/a
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+150.4%
Negative means the company is buying back shares.
Technical

LON/0R55 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
49.7
Neutral momentum band
Price vs 200-day MA
-8.3%
50/200-day relationship not available
Beta (5Y)
-1.67
Less volatile than the market
Sharpe ratio
0.82
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0R55

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R55 stock rating?

lon/0R55 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R55 analysis?

The full report lives at /stocks/lon/0R55/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R55?

The latest report frames lon/0R55 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R55 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.